ArticleFrontiers in neurology
Seizures as the initial manifestation: characterizing the adult phenotype of MOG antibody-associated disease.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CSF/serum IL-6 ratio and its correlation with mri severity in mog antibody-associated cerebral cortical encephalitis: an exploratory pilot study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Clinical Characteristics of Adult MOG Antibody-Associated Disease Presenting with Seizures as the Initial Symptom. Methods: A retrospective analysis was conducted on the clinical data of 7 patients who presented with epileptic seizures as the initial symptom among 16 adult MOG antibody-positive patients admitted to the Department of Neurology at Xingtai People's Hospital in Hebei Province from August 2020 to March 2025. Results: In this study, the age of onset of the 7 patients ranged from 18 to 75 years. All patients presented with epileptic seizures as the initial symptom, with 3 cases accompanied by fever and 4 cases by headache. Among the 7 patients, seizure types included focal seizures and generalized tonic-clonic seizures. Cerebrospinal fluid (CSF) pressure was elevated in 4 cases, while leukocyte count was increased in 2 cases. Cranial magnetic resonance imaging (MRI) revealed cortical lesions in 3 patients without significant meningeal enhancement, and 4 cases showed no abnormal findings on MRI. Electroencephalography (EEG) revealed focal slow waves in 5 cases, while 2 cases showed normal findings. All 7 patients were treated with hormones, 2 received intravenous human immunoglobulin, and 5 were administered antiepileptic drugs. All 7 patients achieved favorable prognosis, with one case of recurrence. Conclusion: In adult MOG antibody-positive patients presenting with epileptic seizures as the initial symptom, the disease can occur at any age without a clear sex predominance. These patients may present with non-specific clinical features such as fever, headache, and abnormalities in cerebrospinal fluid and electroencephalography. Some patients may exhibit isolated epileptic seizures. Cranial magnetic resonance imaging often reveals cortical signal abnormalities. For adult patients presenting with seizures as the first symptom, early MOG antibody testing is essential for a definitive diagnosis. Prompt initiation of corticosteroid or intravenous immunoglobulin therapy can effectively control disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.